"Tavegyl" (meclastine): a pilot trial in allergic rhinitis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000150:complications; D001772:Blood Cell Count; D002648:Child; D002675:Child, Preschool; D004391:Dust; D005260:Female; D005658:Fungi; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D011058:Pollen; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000188:drug therapy*
D004391:Dust; D006634:Histamine H1 Antagonists; D011759:Pyrrolidines